by Dr. Mary Shackelton.
Special to GroupTrails.
This year more than 1.3 million skin cancers will be detected in the United States. Of those, 7300 will be fatal.
We must be careful to employ new methods to protect skin from sun-exposure damage – if we are to reduce the frequency of skin-cancer diagnoses and age-related skin problems.
Until recently, sunscreens have been our best protection from the sun. But their protection is not ideal because of inadequate use, incomplete UVA/UVB protection, and/or toxicity.
In fact, the U.S. Food and Drug Administration says that due to the additional costs and risks from increased concentrations of active ingredients, the maximum SPF should not exceed 30.1
Choose natural sun protection – a hat, sunglasses, and a long-sleeved shirt. And when you and your children race for the outdoors this spring and summer, keep in mind this information to help you choose a safe and natural sunscreen product such as Lavanilla Lab sun screen.
Mary F. Shackelton MPH, ND is a Naturopathic Physician with a practice in Boulder, Colorado. Dr. Shackelton practices family medicine with an emphasis on children’s and women’s health. Within the children’s health specialty she successfully treats most common childhood ailments including: ear infections, immune dysfunction, allergies, eczema, asthma, behavioral disorders, and other chronic illnesses. Dr.Shackelton can be reached at: firstname.lastname@example.org
The content and opinions expressed on this Web page do not necessarily reflect the views of nor are they endorsed by the Grouptrails.com
1 DeSimone EMn: FDA proposes changes in sunscreen regulations. American Pharmacy NS34(6):26-31, 1994
2 Environmental Health Perspectives, Volume 109, Number 3, March 2001,
In Vitro and in Vivo Estrogenicity of UV Screens. Margaret Schlumpf, Beata Cotton, Marianne Conscience, Vreni Haller, Beate
3 Environ Health Perspectives 107 (suppl 6):907-938 (1999).
4 J Am Acad Dermatol 2003, Jan: 48(1): 1-19.
5 Photodermatol Photoimmunol Photomed. 2003 Oct;19(5):242-53.
6 Skin Pharmacol Appl Skin Physiol. 2001 Mar-Apr;14(2):69-76.
7 Anticancer Res. 2002 Nov-Dec;22(6C):3873-7.